Amgen Makes Long-Term Investment in Targeted Therapies with deCODE Genetics Purchase
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 12 (Table of Contents)
Published: 24 Dec-2012
DOI: 10.3833/pdr.v2012.i12.1862 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Amgen has agreed to buy the human genetics specialist deCODE Genetics in an all-cash deal that values the company at US$415 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS